Acta Ortopédica Brasileira (Jan 2022)

PERCUTANEOUS ENDOSCOPIC LUMBAR INTERBODY FUSION: RESULTS OVER 47 MONTHS OF FOLLOW-UP

  • ANIBAL CORREIA SILVA,
  • TABATA DE ALCANTARA,
  • MONICA PASCHOAL NOGUEIRA

DOI
https://doi.org/10.1590/1413-785220223001e249489
Journal volume & issue
Vol. 30, no. 1

Abstract

Read online

ABSTRACT Introduction This study aims to investigate the clinical-functional results of a new surgical technique, Percutaneous Endoscopic Lumbar Interbody Fusion (PELIF), in patients with a clinical diagnosis of low back or sciatic pain and segmental instability who were submitted to surgery using this technique assisted by the attending physician. Materials and methods Patients completed a consent form and were clinically and radiographically re-assessed by independent evaluators using the visual analog scale (VAS) for pain, the Oswestry Disability Index (ODI), and the SF-36 Quality of Life Score in the pre- and postoperative periods. Their medical records were also reviewed for surgical time, length of hospital stay, need for blood transfusion, return to work, and radiographic fusion evaluation. Results In the group of 19 patients with 33 levels operated, VAS and ODI decreased from 10.0 and 64% to 2.0 and 28%, respectively. The SF-36 showed significantly higher scores in 5 of its 7 domains at the end of the follow-up as compared to the preoperative period scores. Only 1 case of pseudoarthrosis was diagnosed radiographically. Conclusions Percutaneous Endoscopic Lumbar Interbody Fusion (PELIF) has been shown to be a safe and efficient technique for the treatment of patients with segmental instability associated with low back or sciatic pain. Level of Evidence VI; Therapeutic Study; Case Series.

Keywords